Transforming Female Reproductive Health Management Vaclav Kirsner Ph

Transforming Female Reproductive Health Management Vaclav Kirsner, Ph. D, Founder bio. Zhena Corporation http: //www. biozhena. com/ vaclav@biozhena. com (970) 484 -1272 Auguste Rodin, The Kiss Profits from the already FDA-cleared application of the Ovulona™ FDA-cleared will support the introduction of the next applications. <<< Pause to click on link to connect. Hover link to read about it. Return here by closing the window.

Women Like Ovulona™ for Birth Control 70% of women who would buy our Ovulona™ Smart Sensor would switch from their current birth control to our fertility status monitor [from a survey of 5, 000 US women].

What does Ovulona™ do? It tracks folliculogenesis in vivo (FIV™) Folliculogenesis is central to women’s health, well -being, and lifestyle. Tracking its course generates menstrual cycle Vital Sign® signatures for physicians and payers Ovulona™ Personal Fertility Smart Sensor Photo of a rapid prototyping model Note: This is not the real prototype. Real details are not shown. And soon it‘ll be transformed into an internally worn telemetric cervica ring <<< Pause to click on link to connect. Hover the link to read about it. Return here by closing the linked window.

What Is Folliculogenesis? The biological foundation of a woman’s well-being. Menstrual cyclic profiles for the women's doctors – like EKG for the doctors caring for the heart.

Data From Home To Healthcare Providers Posteri or Fornix From patients’ Ovulona™ units to a physician’s Ovulograph™ – when needed Folliculogenesis data correlated with auxiliary data (e. g. BBT) Important for OBGYN doctors: The quality of ovulation is strained in normal women - by Richard S. Legro, Human Reproduction, Vol. 28, pp. 1446– 1447, 2013 The OBGYN’s call for help, and a challenge: ‘Improve the methods and criteria used to assess ovulatory dysfunction’. We answer the call.

From late teen age to menopause Click on this link for more: https: //biozhena. files. wordpress. com/2016/12/friendly-technology-wealth-ofinformation-510 k-vltava-fda-nih. pps Click outside of link to exit.

Breakthrough For Trying-To-Conceive Women MOSTLY GIRLS BORN 69% MOSTLY BOYS BORN 77% Male spermatozoa (Y-chromosomebearing sperm) live longer than female spermatozoa (X-chromosome-bearing sperm) G. D. Hodgen et al. , Andrologia 33, 199 al. (2001) FERTILE DAY 1 2 3 J. T. France et al. , "Characteristics of natural conception cycles occurring in a prospective study of sex preselection. . . ", Int J Fertility 37 (4), 224 - 255, 1992 • • Precise determination of the 3 -day fertile window Clear daily indications: FERTILE DAY # or mostly INFERTILE Easy to use Smart Ovulona™ and next generation Halo™ telemetric cervical ring Automatically detects & monitors pregnancy, computes Expected Delivery Date Requires no chemical work, no graphing, no interpretation of data by the user Provides folliculogenesis profile vital signature data to physicians and payers Provides innocuous inexpensive built-in screen for cervical cancer, other STDs

Ovulation prediction products Two recent IT products do not determine the 3 -day fertile window - like the others , merely like the others predict ovulation, 6 days assumed “Only worn during the night, the Ava , a fertility-tracking wearable device" is an IT adaptation of the old approach to an estimating ovulation via numerous variables, here "9 parameters [to] detect the beginning of a woman’s fertile window. . . including breathing rate, sleep quality, pulse rate, heart rate variability, temperature [etc]". For people "deserve to enjoy the baby-making process". A very expensive IT adaptation of the old BBT technique that does not (cannot) anticipate ovulation. Their counselors help infertility sufferers to practice “focused intercourse” aiming to avoid or at least minimize the high costs of Artificial Reproductive Technologies (ARTs).

Comparison of technologies in the Trying-To-Conceive self-help market This is Ovulona monitor’s first application, FDA-ready for market Ovulona™ BBT Thermo meters LH kits urine chemistry Saliva magnifying glasses Body fluid Conductivity Precision High Low Low Reliability High Low Low Immediacy of results Yes No Convenience of use Yes No Characteristics “Price Is Not An Advertising Yes Point In This Category” Information content High Of Trying-To-Conceive Women Low cost of ownership Yes Low Yes “Chief Selling Points Are Can be used to preselect baby’s sex? Yes Simplicity And Can it do built-in pregnancy check? Yes Accuracy” No Can it compute date of delivery? [marketresearch. com] Can be used for birth control? Points “Chief Selling No Yes The No Ovulona provides No Yes the best quality, Low the most value No No per dollar spent No No No Yes Low No No No Yes No No Folliculogenesis profile for healthcare? Yes No No Multi-purpose long-term use? Yes No No See Market. Research. com: http: //www. marketresearch. com/Packaged-Facts-v 768/Home-Medical-Tests-143386 / In TOC scroll down to section IV. http: //www. marketresearch. com/Packaged-Facts-v 768/Home-Medical-Tests-143386 See also “Corporate venturing: the origins of Unilever's pregnancy test“ http: //dx. doi. org/10. 1080/00076790412331270139.

Sure Bet! Natural reproductive management is inevitably preferred over the alternatives IT IMPROVES QUALITY OF PLEASURE • We humans are pleasure - seeking organisms OUR FUNDAMENTAL DRIVING FORCE • Our brain prefers “ancient” sensory pleasures - including “natural” sex Ref. : ANTHROPOLOGY –“The Pursuit of Pleasure” by Lionel Tiger, 1992 And for Investors – PPM